Rania Rifaey, MD
Anesthesiology · Wallingford, CTNPI 1255666350
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,436 of the $4,971 with a category attached, or 69.1%. 13 manufacturers reported payments, led by Abbott at 39.8% of the total. Reporting peaked in 2019 at $2,300 and has fallen 98.7% since, to $30 in 2025. Among anesthesiology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $93.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Nevro Corp.$2K
- Medtronic$544
- SPR Therapeutics, Inc$508
- Orthofix Medical, Inc.$48
- Relievant Medsystems, Inc.$31
- plus $138 from 7 others
What the payments were for
- Travel & lodging$3,43669%
- Food & beverage$1,53531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 14 | $1,976 |
| Nevro Corp. | 18 | $1,726 |
| Medtronic | 8 | $544 |
| SPR Therapeutics, Inc | 2 | $508 |
| Orthofix Medical, Inc. | 3 | $48 |
| Relievant Medsystems, Inc. | 1 | $31 |
| Zimvie Inc. | 1 | $24 |
| Stryker | 1 | $24 |
| Si-bone, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| AbbVie | 1 | $19 |
| Boston Scientific | 1 | $18 |
| Bioventus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,971 in reported general payments places this provider in the 95th percentile of 664 anesthesiology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 43 | $11,326 |
| Gabapentin | 514 | $7,179 |
| Pregabalin | 192 | $4,322 |
| Tizanidine Hcl | 51 | $704 |
| Cyclobenzaprine Hcl | 60 | $576 |
| Methylprednisolone | 69 | $426 |
| Celecoxib | 14 | $413 |
| Amitriptyline Hcl | 24 | $366 |
| Tramadol Hcl | 40 | $323 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $250 |
| Oxycodone Hcl | 21 | $75 |
| Meloxicam | 11 | $33 |
| Diazepam | 19 | $11 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Wallingford
- Zeev KainNew Haven$273K
- Alison ConsidineNew Haven$82K
- Sanjay SinhaHartford$42K
- William RosenblattNew Haven$40K
- Paul HeerdtNew Haven$36K
- Antonio PazBrookfield$27K
- Honghui FengOld Saybrook$20K
- Prakash PatelNew Haven$20K
- Aymen AlianNew Haven$17K
- Theresa BowlingShelton$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.